Restless Legs Syndrome (RLS) is a neurological disorder that becomes more common during the menopause transition.
How common? RLS affects about 5-10% of the general population, but prevalence rises to 20-25% in perimenopausal women. The SWAN Study confirmed that the transition period is a high-risk window.
Why menopause? Estrogen influences dopamine signaling, and dopamine dysfunction is central to RLS. Hormonal fluctuations during perimenopause may unmask a latent tendency or worsen existing RLS.
Diagnostic criteria (IRLSSG): 1) Urge to move legs, 2) Worse at rest, 3) Relieved by movement, 4) Worse in evening/night, 5) Not explained by another condition.
First-line treatment:
- Check ferritin — if serum ferritin is below 75 mcg/L, iron supplementation is first-line. Many women are iron deficient from heavy periods.
- Avoid triggers — caffeine, alcohol, antihistamines, and some antidepressants worsen RLS
- Moderate exercise — regular walking significantly reduces symptoms
- Magnesium — some evidence for mild symptom reduction
⚠️ If iron supplementation and lifestyle changes do not help, see a sleep specialist. Prescription medications exist but have side effects.